Bendamustine and Bevacizumab for Advanced Cancers

NCT01152203 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: Bendamustine
DRUG: Bevacizumab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]